Education
About Us
Working with TipRanks
Follow Us
Zura Bio (ZURA)
NASDAQ:ZURA
Total Valuation
Zura Bio has a market cap or net worth of $280.25M. The enterprise value is -$42.28M.
Market Cap$280.25M
Enterprise Value-$42.28M
Share Statistics
Zura Bio has 65,023,310 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding65,023,310
Owned by Insiders7.69%
Owned by Institutions45.85%
Financial Efficiency
Zura Bio’s return on equity (ROE) is -0.31 and return on invested capital (ROIC) is -34.49%.
Return on Equity (ROE)-0.31
Return on Assets (ROA)-0.25
Return on Invested Capital (ROIC)-34.49%
Return on Capital Employed (ROCE)-0.34
Revenue Per Employee0.00
Profits Per Employee-1.75M
Employee Count30
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Zura Bio is ―. Zura Bio’s PEG ratio is 0.06.
PE Ratio―
PS Ratio0.00
PB Ratio1.28
Price to Fair Value1.28
Price to FCF-6.67
Price to Operating Cash Flow-6.86
PEG Ratio0.06
Income Statement
In the last 12 months, Zura Bio had revenue of 0.00 and earned -52.40M in profits. Earnings per share was -0.60.
Revenue0.00
Gross Profit0.00
Operating Income-55.19M
Pretax Income-52.40M
Net Income-52.40M
EBITDA-55.18M
Earnings Per Share (EPS)-0.60
Cash Flow
In the last 12 months, operating cash flow was -53.36M and capital expenditures -141.00K, giving a free cash flow of -53.50M billion.
Operating Cash Flow-53.36M
Free Cash Flow-53.50M
Free Cash Flow per Share-0.82
Dividends & Yields
Zura Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.52
52-Week Price Change61.42%
50-Day Moving Average3.82
200-Day Moving Average2.18
Relative Strength Index (RSI)62.78
Average Volume (3m)2.99M
Important Dates
Zura Bio upcoming earnings date is Apr 1, 2026, Before Open (Confirmed).
Last Earnings DateNov 13, 2025
Next Earnings DateApr 1, 2026
Ex-Dividend Date―
Financial Position
Zura Bio as a current ratio of 9.16, with Debt / Equity ratio of 0.00%
Current Ratio9.16
Quick Ratio9.16
Debt to Market Cap0.00
Net Debt to EBITDA3.37
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Zura Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Zura Bio EV to EBITDA ratio is -0.21, with an EV/FCF ratio of -0.40.
EV to Sales0.00
EV to EBITDA-0.21
EV to Free Cash Flow-0.40
EV to Operating Cash Flow-0.40
Balance Sheet
Zura Bio has $139.02M in cash and marketable securities with $0.00 in debt, giving a net cash position of $139.02M billion.
Cash & Marketable Securities$139.02M
Total Debt$0.00
Net Cash$139.02M
Net Cash Per Share$2.14
Tangible Book Value Per Share$2.13
Margins
Gross margin is -950.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-950.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Zura Bio is $16.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$16.50
Price Target Upside282.83% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast-19.69%